SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950005-96-000913
Filing Date
1996-11-14
Accepted
1996-11-14 00:00:00
Documents
4
Period of Report
1996-09-30
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT 10-Q 36466
2 COLLABORATION AGREEMENT EX-10.32 173901
3 COMPUTATION OF NET INCOME EX-11 2406
4 FINANCIAL DATA SCHEDULE EX-27 2424
  Complete submission text file 0000950005-96-000913.txt   216834
Mailing Address
Business Address 3832 BAY CENTER PLACE HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Filer) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22570 | Film No.: 96663346
SIC: 2833 Medicinal Chemicals & Botanical Products